PTC Therapeutics (NASDAQ:PTCT) Upgraded to “Strong-Buy” at StockNews.com
PTC Therapeutics (NASDAQ:PTCT – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Thursday. A number of other brokerages have also weighed in on PTCT. Bank of America upgraded PTC Therapeutics from an “underperform” rating to a “neutral” […]
